62 Chapter 4 Figure 1 Effect after reevaluation of study cases using updated staging criteria on classification of patients into low risk versus intermediate/ high risk. * Note, in 11 out of the 119 discrepant cases, the change in risk classification was clearly due to interpretation differences (rather than use of updated criteria) between the original staging reports and the expert-re-evaluation: 7 cases originally staged as cT4 were downstaged to low-risk cT12-3ab disease, 2 cases originally staged as cT1-2 MRF+ were re-evaluated as cT1-2 MRF-, and 2 cases originally staged as cT1-2 MRF- were re-evaluated as cT3 MRF+. This left a total of 108/604 = 17.9% remaining discrepant cases.
RkJQdWJsaXNoZXIy MjY0ODMw